Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Lilly's next-gen obesity drug brings Innovent a phase 3 win in diabetes
Fierce Biotech
Thu, 05/9/24 - 11:48 am
Innovent
Eli Lilly
mazdutide
obesity
type 2 diabetes
Lilly gets a date with FDA to discuss Alzheimer's med donanemab
Fierce Biotech
Tue, 05/7/24 - 11:21 am
Eli Lilly
FDA
advisory committees
Alzheimer's disease
donanemab
Eli Lilly Gears Up for Donanemab Adcomm as FDA Ponders Changes to Format
BioSpace
Mon, 05/6/24 - 11:43 am
Eli Lilly
FDA
donanemab
advisory committees
Alzheimer's disease
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool
Sun, 05/5/24 - 11:40 pm
Prizer
danuglipron
obesity
Eli Lilly
Novo Nordisk
Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss
Fierce Biotech
Thu, 05/2/24 - 10:14 pm
Regeneron
Eli Lilly
Zepbound
obesity
trevogrumab
bimagrumab
How Lilly is using its Mounjaro millions to position as biotechs’ ‘partner of choice’
Fierce Biotech
Wed, 05/1/24 - 10:55 am
Eli Lilly
Gateway Labs
incubators
Mounjaro
biotech
Eli Lilly’s growth drivers, Verzenio and Jardiance, suffer clinical setbacks
Fierce Pharma
Tue, 04/30/24 - 11:20 am
Eli Lilly
Jardiance
Verzenio
clinical trials
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance
Tue, 04/30/24 - 08:56 am
Novo Nordisk
Eli Lilly
earnings
obesity
weight loss
GLP-1 agonist
Ozempic
Wegovy
Zepbound
Mounjaro
Eli Lilly lifts sales view by $2 billion on soaring weight-loss drug demand
Reuters
Tue, 04/30/24 - 08:33 am
Eli Lilly
earnings
Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Clinical Trials Arena
Mon, 04/29/24 - 11:24 am
Eli Lilly
merestinib
clinical trials
solid tumors
Why the obesity drug market is about to get a lot more crowded
Medical Marketing and Media
Fri, 04/26/24 - 11:49 am
obesity
Novo Nordisk
Wegovy
Eli Lilly
Zepbound
Roche
AstraZeneca
As Lilly and BMS invest in manufacturing, demand for drugs still outweighs supply
Pharma Voice
Fri, 04/26/24 - 11:47 am
drug shortages
drug manufacturing
Eli Lilly
Bristol Myers Squibb
Endeavor pulls in $132M to back cancer, lung disease drugs
BioPharma Dive
Wed, 04/24/24 - 08:45 am
Endeavor BioMedicines
funding
IPF
Eli Lilly
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
Motley Fool
Wed, 04/24/24 - 08:43 am
Eli Lilly
weight loss
Zepbound
Big Pharma market caps surge to start 2024 despite economic headwinds
Medical Marketing and Media
Tue, 04/23/24 - 10:38 am
Big Pharma
market cap
Novo Nordisk
Eli Lilly
Lilly to buy injectable drug plant in manufacturing ramp-up
BioPharma Dive
Mon, 04/22/24 - 05:54 pm
Eli Lilly
drug manufacturing
Mounjaro
Zepbound
Wisconsin
Roche’s Early Alzheimer’s Blood Test Gets FDA Breakthrough Device Designation
Xtalks
Thu, 04/18/24 - 10:28 pm
Roche
FDA
Medtech
Eli Lilly
Elecsys pTau217
Alzheimer's disease
diagnostics
Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At
Forbes
Thu, 04/18/24 - 10:25 pm
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
anxiety
addiction
heart disease
liver disease
Lilly Alzheimer's med glides out of Leqembi's slipstream with FDA adcomm request
Fierce Biotech
Wed, 04/17/24 - 09:58 pm
Eli Lilly
donanemab
Alzheimer's disease
Leqembi
Biogen
Eisai
FDA
Lilly eyes Zepbound label expansion after clearing phase III sleep apnea study
BioSpace
Wed, 04/17/24 - 11:32 am
Eli Lilly
Zepbound
sleep apnea
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »